Log on / register
BioMed Central home | Journals A-Z | Feedback | Support | My details

Email this article to a friend

Zoledronic acid increases docetaxel cytotoxicity through pMEK and Mcl-1 inhibition in a hormone-sensitive prostate carcinoma cell line

Francesco Fabbri email, Giovanni Brigliadori email, Silvia Carloni email, Paola Ulivi email, Ivan Vannini email, Anna Tesei email, Rosella Silvestrini email, Dino Amadori email and Wainer Zoli email

Journal of Translational Medicine 2008, 6:43doi:10.1186/1479-5876-6-43

Your name*
Your email address*
Recipient's email address*
(multiple email addresses should be separated with commas)
Email format
Please type your message into the box below:
Terms and Conditions Privacy statement Information for advertisers Jobs at BMC Contact us
© 1999-2009 BioMed Central Ltd unless otherwise stated. Part of Springer Science+Business Media.